145 related articles for article (PubMed ID: 35288899)
1. Antinuclear antibodies in children: clinical signification and diagnosis utility.
Mejdoub S; Hachicha H; Gargouri L; Feki S; Mahfoudh A; Masmoudi H
Tunis Med; 2021 Octobre; 99(10):980-984. PubMed ID: 35288899
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura.
Altintas A; Ozel A; Okur N; Okur N; Cil T; Pasa S; Ayyildiz O
J Thromb Thrombolysis; 2007 Oct; 24(2):163-8. PubMed ID: 17436144
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence and diagnostic value of antinuclear antibodies without identified antigenic target: a retrospective study of 90 patients].
Feki S; Frikha F; Ben Hadj Hmida Y; Abed S; Ben Ayed M; Turki H; Hachicha J; Baklouti S; Bahloul Z; Masmoudi H
Rev Med Interne; 2012 Sep; 33(9):475-81. PubMed ID: 22658165
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of antinuclear antibody tests in children.
McGhee JL; Kickingbird LM; Jarvis JN
BMC Pediatr; 2004 Jul; 4():13. PubMed ID: 15245579
[TBL] [Abstract][Full Text] [Related]
5. The clinical utility of a positive antinuclear antibody test result.
Abeles AM; Abeles M
Am J Med; 2013 Apr; 126(4):342-8. PubMed ID: 23395534
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of borderline results of the Elia CTD Screen assay.
Robier C; Amouzadeh-Ghadikolai O
Clin Chem Lab Med; 2018 Nov; 56(12):2088-2092. PubMed ID: 30032128
[TBL] [Abstract][Full Text] [Related]
7. Antinuclear antibody testing in a Turkish pediatrics clinic: is it always necessary?
Aygün E; Kelesoglu FM; Dogdu G; Ersoy A; Basbug D; Akça D; Çam ÖN; Akyüz B; Günsay T; Kapici AH; Aydin NG; Karapinar E; Atay S; Saglam N; Okumus NK; Can MZ; Yazici F; Ömeroglu RE
Pan Afr Med J; 2019; 32():181. PubMed ID: 31312295
[TBL] [Abstract][Full Text] [Related]
8. Antinuclear antibodies positivity is not rare during multiple sclerosis and is associated with relapsing status and IgG oligoclonal bands positivity.
Mejdoub S; Feki S; Farhat N; Dammak M; Hachicha H; Sakka S; Ayedi A; Ayedi F; Mhiri C; Masmoudi H
Rev Neurol (Paris); 2022 Oct; 178(8):812-816. PubMed ID: 35589445
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic significance of antinuclear antibodies].
Swaak AJ
Ned Tijdschr Geneeskd; 2000 Mar; 144(13):585-9. PubMed ID: 10761543
[TBL] [Abstract][Full Text] [Related]
10. [Modern look at the problems of investigation of antinuclear antibodies in systemic lupus erythematosus (literature review).].
Aleksandrova EN; Verizhnikova ZG; Novikov AA; Lukina GV
Klin Lab Diagn; 2018; 63(6):340-348. PubMed ID: 30702224
[TBL] [Abstract][Full Text] [Related]
11. Clinical use of anti-DFS70 autoantibodies.
Kang SY; Lee WI; Kim MH; La Jeon Y
Rheumatol Int; 2019 Aug; 39(8):1423-1429. PubMed ID: 30972541
[TBL] [Abstract][Full Text] [Related]
12. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
[TBL] [Abstract][Full Text] [Related]
13. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
[TBL] [Abstract][Full Text] [Related]
14. Detection of anti-nuclear antibody by immunofluorescence assay and enzyme immunoassay in childhood systemic lupus erythematosus: experience from Bangladesh.
Dipti TR; Azam MS; Sattar MH; Rahman SA
Int J Rheum Dis; 2012 Feb; 15(1):121-5. PubMed ID: 22324956
[TBL] [Abstract][Full Text] [Related]
15. Assessment of ideal serum dilution for screening of antinuclear antibodies by an indirect immunofluorescence method in diagnosis of autoimmune disorders.
Vasdev V; Patnaik SK; Bhakuni DS; Shanmuganandan K; Bhayana A; Mullick G; Hegde A; Kumar A; Kumar A; Singh R
Med J Armed Forces India; 2022 Jan; 78(1):54-60. PubMed ID: 35035044
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of determination of DFS70 antibodies to rule out connective tissue diseases].
Kiefer D; von Brunn M; Baraliakos X; Andreica I; Braun J
Z Rheumatol; 2020 Oct; 79(8):749-754. PubMed ID: 31889213
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of the antinuclear antibody test in selected children with idiopathic thrombocytopenic purpura.
Zimmerman SA; Ware RE
J Pediatr Hematol Oncol; 1997; 19(4):297-303. PubMed ID: 9256827
[TBL] [Abstract][Full Text] [Related]
18. The clinical relevance of anti-dsDNA antibodies determined by the Elia™ dsDNA assay in patients with negative indirect immunofluorescence on the HEp-2 cell.
Robier C; Haas M; Quehenberger F
Clin Chem Lab Med; 2021 Feb; 59(3):541-546. PubMed ID: 33064668
[TBL] [Abstract][Full Text] [Related]
19. Measurement of antinuclear antibodies and their fine specificities: time for a change in strategy?
Otten HG; Brummelhuis WJ; Fritsch-Stork R; Leavis HL; Wisse BW; van Laar JM; Derksen RHWM
Clin Exp Rheumatol; 2017; 35(3):462-470. PubMed ID: 28240588
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of antinuclear antibodies by indirect immunofluorescence and line immunoassay methods': four years' data from Turkey.
Sener AG; Afsar I; Demirci M
APMIS; 2014 Dec; 122(12):1167-70. PubMed ID: 24735346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
